GZMB and myeloid sarcoma: While GzmB has been shown to promote Treg resistance through a novel, apoptosis-independent pathway, memory GzmB was not expressed by CD4+CD127loFOXP3+ Treg subtypes but was represented by stimulated, nonregulatory CD4+ T cells separated from patients with MS [197].